HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Odile Leroy Selected Research

Aluminum Hydroxide (Algeldrate)

1/2020PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.
10/2019First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.
1/2019The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers.
1/2016Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.
1/2012Humoral immune responses to a single allele PfAMA1 vaccine in healthy malaria-naïve adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Odile Leroy Research Topics

Disease

25Malaria
04/2021 - 12/2005
3Infections
01/2020 - 01/2016
2Vaccinia
08/2016 - 01/2016
2Falciparum Malaria (Plasmodium falciparum Malaria)
01/2015 - 01/2015
2Communicable Diseases (Infectious Diseases)
12/2014 - 07/2014
2Tetanus
06/2002 - 04/2002
2Diphtheria
06/2002 - 04/2002
2Pneumococcal Infections
06/2002 - 04/2002
1Infant Death
04/2019
1Rabies (Hydrophobia)
09/2010
1Abscess
01/2008
1Erythema
01/2008
1Whooping Cough (Pertussis)
04/2002

Drug/Important Bio-Agent (IBA)

20VaccinesIBA
01/2020 - 04/2002
9AntigensIBA
04/2019 - 12/2005
7Malaria VaccinesIBA
01/2020 - 11/2009
5Aluminum Hydroxide (Algeldrate)FDA Link
01/2020 - 01/2012
5Proteins (Proteins, Gene)FDA Link
01/2017 - 04/2002
2EmulsionsIBA
10/2019 - 01/2019
2LipidsIBA
10/2019 - 01/2019
2Rabies Vaccines (Rabies Vaccine)FDA Link
01/2019 - 01/2016
2ThrombospondinsIBA
01/2017 - 08/2016
2EpitopesIBA
01/2017 - 08/2016
2Merozoite Surface Protein 1 (MSA1)IBA
01/2015 - 01/2015
2Pharmaceutical PreparationsIBA
01/2014 - 12/2011
2AntibodiesIBA
04/2007 - 12/2005
2Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link
06/2002 - 04/2002
2Polysaccharides (Glycans)IBA
06/2002 - 04/2002
2Conjugate VaccinesIBA
06/2002 - 04/2002
2Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
06/2002 - 04/2002
1Immunoglobulin G (IgG)IBA
04/2021
1saponin QA-21V1 (QS21)IBA
10/2019
1Protein Subunit VaccinesIBA
01/2019
1InsecticidesIBA
01/2016
1Antimalarials (Antimalarial Agents)IBA
01/2016
1Recombinant ProteinsIBA
01/2015
1ChondroitinIBA
01/2015
1RNA (Ribonucleic Acid)IBA
07/2014
1N-acetyltalosaminuronic acid (NAT)IBA
01/2014
1Nucleic AcidsIBA
01/2014
1mannide monooleateIBA
01/2012
1Complement System Proteins (Complement)IBA
11/2009
1Monatide (IMS 3015)IBA
01/2008
1hydroxide ionIBA
03/2007
1AluminumIBA
03/2007
1Interferon-gamma (Interferon, gamma)IBA
12/2005
1Poliovirus VaccinesIBA
04/2002
1aluminum sulfate (alum)IBA
04/2002
1Measles VaccineIBA
04/2002
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
04/2002
1Phosphates (Orthophosphate)IBA
04/2002

Therapy/Procedure

1Intramuscular Injections
10/2019